New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 8, 2012
07:27 EDTCBLICleveland BioLabs reports Q3 EPS (30c) vs (8c) in Q3 of 2011
Reports Q3 R&D expenses down to about $4.8M. Revenues for Q3 decreased to approximately $0.2M from approximately $3.8M in Q3 of 2011, primarily due to decreases in research sponsored by the DoD, BARDA and a NY State/RPCI Sponsored Research Agreement.
News For CBLI From The Last 14 Days
Check below for free stories on CBLI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for CBLI

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use